Sensei Biotherapeutics

An innovator in the field of next-generation cancer immunotherapies.

Launch date

1999

Employees

Market cap

Enterprise valuation

(CAD47m) (Public information from Sep 2024)

Gaithersburg Maryland (HQ)

https://senseibio.com

https://twitter.com/senseibio https://www.linkedin.com/company/sensei-bio/

View job openings

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
EBITDA	(18.0m)	(36.0m)	(50.2m)	(32.3m)	(33.9m)	(40.1m)	(47.5m)
Profit	(20.1m)	(36.8m)	(48.6m)	(34.1m)	(31.4m)	(37.0m)	(43.5m)
EV / EBITDA	-	-0.9x	1.1x	-0.5x	-0.5x	-0.4x	-0.3x
R&D budget	11.2m	21.7m	30.4m	18.3m	-	-	-

Date	Investors	Amount	Round
-	Parsec Investment	N/A	-
Oct 2020	Apeiron Investment Group Future Ventures H&S Ventures Presight Capital Cambrian BioPharma	$28.5m	Series A
Jan 2021	Apeiron Investment Group Pura Vida Investments Future Ventures Presight Capital Cambrian BioPharma Moore Strategic Ventures Catalio Capital Management	$30.0m	Series B
Feb 2021	N/A	$133m	IPO
Total Funding		CAD79.8m

Tech stackLearn more about the technologies and tools that this company uses.